Turning the TIDE: oligonucleotide development trends
Discover what is driving the oligonucleotide therapeutics sector as scientists navigate challenges such as financing and success-to-market.
Stay updated with breaking news from Michael Postlethwaite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Discover what is driving the oligonucleotide therapeutics sector as scientists navigate challenges such as financing and success-to-market.
Press release content from Business Wire. The AP news staff was not involved in its creation. AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members January 7, 2021 GMT NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--Jan 7, 2021-- AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly 50,000 m 2 of manufacturing, quality control and administrative space. “We have added 4 new buildings which add to our solid-phase and liquid-phase peptide facilities at our Shanghai production site posi...